Burney CO Biogen Inc. Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Biogen Inc. stock. As of the latest transaction made, Burney CO holds 1,961 shares of BIIB stock, worth $292,228. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,961

Previous 1,976 0.76%

Holding current value

$292,228

Previous $458,000 17.03%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$189.07 - $236.8 $2,836 - $3,552	-15 Reduced 0.76%	1,961 $380,000
Q2 2024 Jul 29, 2024	SELL	$190.52 - $236.72 $31,435 - $39,058	-165 Reduced 7.71%	1,976 $458,000
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $57,873 - $69,664	-260 Reduced 10.83%	2,141 $554,000
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $233,036 - $263,018	920 Added 62.12%	2,401 $617,000
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $59,178 - $68,382	-215 Reduced 12.68%	1,481 $421,000
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $137,259 - $156,401	-535 Reduced 23.98%	1,696 $471,000
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $155,250 - $188,632	-615 Reduced 21.61%	2,231 $617,000
Q3 2022 Nov 15, 2022	SELL	$194.69 - $268.46 $29,787 - $41,074	-153 Reduced 5.1%	2,846 $760,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $31,694 - $37,690	-169 Reduced 5.33%	2,999 $612,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $320,689 - $404,051	-1,655 Reduced 34.31%	3,168 $667,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $138,382 - $177,841	-618 Reduced 11.36%	4,823 $1.16 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $25,752 - $33,583	-91 Reduced 1.64%	5,441 $1.54 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $26,159 - $41,885	-101 Reduced 1.79%	5,532 $1.92 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $143,097 - $167,647	-589 Reduced 9.47%	5,633 $1.58 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $1.23 Million - $1.86 Million	-5,223 Reduced 45.64%	6,222 $1.52 Million
Q3 2020 Dec 14, 2020	BUY	$264.77 - $305.71 $291,247 - $336,281	1,100 Added 10.63%	11,445 $3.25 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $1.11 Million - $1.46 Million	4,275 Added 70.43%	10,345 $2.77 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $116,412 - $147,670	-433 Reduced 6.66%	6,070 $1.92 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $96,386 - $133,182	438 Added 7.22%	6,503 $1.93 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $959,780 - $1.08 Million	-4,414 Reduced 42.12%	6,065 $1.41 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $6.81 Million - $7.51 Million	-31,059 Reduced 74.77%	10,479 $2.45 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $137,394 - $214,900	634 Added 1.55%	41,538 $9.82 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $388,786 - $492,439	1,396 Added 3.53%	40,904 $12.3 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.08 Million - $1.41 Million	-3,685 Reduced 8.53%	39,508 $14 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $405,851 - $483,690	1,576 Added 3.79%	43,193 $12.5 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $100,150 - $141,645	385 Added 0.93%	41,617 $11.4 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $3.17 Million - $3.55 Million	10,311 Added 33.35%	41,232 $13.1 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $5.66 Million - $6.63 Million	20,116 Added 186.17%	30,921 $9.59 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $3.04 Million - $3.56 Million	10,805	10,805 $2.94 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account